Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms on their most important mergers, acquisitions and takeover transactions.
Jim Langston Discusses His Career and the 2024 Dealmaking Environment With Axios
June 1, 2024
Axios spotlighted corporate partner Jim Langston, focusing on his recent move to Paul, Weiss, his predictions for dealmaking in the second half of the year, and the trends that he’s watching, among others. In the article, “1 Big Thing: Jim Langston Joins Paul Weiss,” published on June 1 in Axios Pro: Health Tech Deals, Jim predicts that the second half of the year will be ripe for dealmaking, particularly in the tech and pharma industries, driven by increased certainty around interest rates and increased confidence within C-suites and boardrooms.
"That value disconnect has been a hard puzzle to solve over the last 12 to 18 months, but it's getting easier," Jim says. "Dry powder has to get invested and limited partners want private equity to return capital. That's going to accelerate a lot of M&A activity."
» read the article (subscription required)